YUKI SNELGROVE: Open Payments
NPI 1881396695 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 48 payments from 9 companies in 2025. Trend: 2023 $413 · 2024 $1,576 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 15 | $459 |
| PFIZER INC. | 13 | $212 |
| ABBVIE INC. | 9 | $179 |
| Janssen Biotech, Inc. | 2 | $177 |
| Madrigal Pharmaceuticals | 4 | $93 |
| Celltrion USA Inc. | 2 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: TREMFYA, Vemlidy, XELJANZ, Epclusa, CREON, REZDIFFRA, VEGZELMA, VELSIPITY.
Industry payments across HI — which companies pay providers there.
